Liver injury after beginning antiretroviral therapy in HIV/hepatitis C virus co-infected patients is not related to immune reconstitution

Luz Martín-Carbonero, Marina Núñez, Pilar Ríos, Mayte Pérez-Olmeda, Juan González-Lahoz, Vincent Soriano

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

Transaminase elevations occur more frequently after beginning antiretroviral therapy in HIV-positive patients co-infected with hepatitis C virus (HCV). The mechanism of liver injury in these individuals is unknown, although immune reconstitution phenomena have been postulated. In 42 HIV/HCV co-infected individuals followed after beginning potent antiretroviral therapy, the development of liver injury was not associated with significant changes in serum HCV-RNA levels nor with greater CD4 cell increases. Underlying chronic hepatitis may thus increase the risk of liver toxicity by other mechanisms.

Original languageEnglish (US)
Pages (from-to)1423-1425
Number of pages3
JournalAIDS
Volume16
Issue number10
DOIs
StatePublished - Jul 5 2002

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Liver injury after beginning antiretroviral therapy in HIV/hepatitis C virus co-infected patients is not related to immune reconstitution'. Together they form a unique fingerprint.

Cite this